Search

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Counterfeit deterrents are not yet available in some regions. We speak with Advanco CEO Alf Goebel to find out why.

Biosimilars, Switzerland and more; we interview Anne Marie de Jonge-Schuermans from the Swiss Biotech Association.

Biological engineering project featuring GSK seeks to use food by-products to create antimicrobials.

We ask about the story behind Nanoform and what nanotechnology could do for drug formulation.

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

Preparing for the EU’s new HTA regulation and Joint Clinical Assessment process

Veeva’s Richard Young looks back on breakthroughs in clinical trial technology and why the industry must continue to make trials more patient centric.

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

We ask an expert from Elsevier about the future of digital tech in drug discovery.